EU cell therapy companies Cell Medica, Promethera raise cash

Two European companies focused on cell therapies have raised money from private investors: the UK's Cell Medica has raised a £50m series B round, and Belgium's Promethera Biosciences has raised €25.33m in a combination of series C investment and loans and subsidies.